Drug and Substance Abuse


Purdue’s Sacklers, states reach Opioid deal valued at up to $6 billion

Members of the Sackler family who own Purdue Pharma LP and grew wealthy from sales of OxyContin agreed to pay up to $6 billion to settle lawsuits accusing them of helping fuel the opioid-addiction epidemic, earning the unanimous support of state attorneys general to resolve the family’s liability and end the drugmaker’s bankruptcy case.


Appeals are mounting in Purdue Pharma bankruptcy settlement

Objections to a historic settlement with Purdue Pharma are mounting in the form of appeals, with Rhode Island's attorney general saying Wednesday the plan doesn't hold the OxyContin maker or its owners accountable for its role in sparking the opioid crisis.